Loading...
BRCA1/2 testing: therapeutic implications for breast cancer management
Testing for germline BRCA1/2 mutations has an established predictive role in breast cancer risk assessment. More recently, studies have also identified BRCA1/2 status as clinically relevant in the selection of therapy for patients already diagnosed with breast cancer. Emerging breast and ovarian can...
Na minha lista:
| Udgivet i: | Br J Cancer |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6048046/ https://ncbi.nlm.nih.gov/pubmed/29867226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0127-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|